Press Releases

AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications - August 20, 2024

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy platform, today announced it has entered into a strategic agreement… Read More

Read: https://www.businesswire.com/news/home/20240820091686/en/AVS-Partners-with-the-…

Available Press Releases

AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study - June 6, 2024

AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs - February 6, 2024

AVS Opens Global Headquarters in Boston’s Seaport District to Support Growth - September 21, 2023

AVS’s Pulsatile Intravascular Lithotripsy Technology Attracts an Additional $8.8M to Close $28.8M Series B Round - April 4, 2023

AVS Raises $20 Million in Series B Round to Advance Pulsatile Intravascular Lithotripsy (PIVL) Solutions - January 5, 2023

AVS Announces Multi-Site Enrollment of First Patients in POWER PAD I Clinical Trial and Appointment of William H. Kucheman to Board of Directors - September 15, 2022